Most women picture menopause as something that arrives slowly, year by year, with time to adjust.
There are hot flashes, mood shifts, maybe a change in sleep. The body gets a chance to catch up.
For women going through cancer treatment, that gentle timeline often disappears.
Chemotherapy, surgery to remove the ovaries, and hormone-blocking drugs can shut down ovarian function in a matter of days or weeks.
Also read: New study: These changes may reverse type 2 diabetes in just 6 months
Doctors call it treatment-induced or complex menopause. Because the drop in estrogen is abrupt rather than gradual, the hot flashes, joint pain and mood changes tend to arrive faster and hit harder than they do in natural menopause.
Which cancer therapies set it off
The main triggers come from the treatments that reach reproductive tissue.
According to Breastcancer.org, chemotherapy regimens that use cyclophosphamide, the drug sold as Cytoxan, commonly push women into menopause.
The reason is that the drug destroys the rapidly dividing cells in the ovaries along with the cancer cells it is meant to treat.
Also read: Want to keep your brain healthy? These activities may help
Surgery to remove both ovaries, called an oophorectomy, triggers menopause instantly.
Hormone-blocking drugs taken after breast cancer, such as tamoxifen or aromatase inhibitors, do not shut the ovaries down permanently but produce similar symptoms while a woman is on them.
Why the symptoms land harder
Natural menopause unfolds over several years. The ovaries wind down gradually, and the body adjusts to lower hormone levels bit by bit.
After cancer treatment, that cushion is gone.
Also read: Scientists discover your voice may reveal how fast your brain is aging
Estrogen can drop in days, which is why hot flashes, night sweats, insomnia, joint aches and low mood often arrive together and at full strength.
Most women are not warned beforehand
A systematic review published in July 2026 in the journal Support Care Cancer looked at the unmet needs of cancer survivors going through menopause.
The researchers, led by Dorcas Serwaa, found that 60 percent of women did not receive information about their risk of early menopause before treatment.
Between a quarter and a third got no information about treatment-induced menopause at all.
Also read: Forget chicken: These grains are packed with protein
The gap continues afterward. Across the studies reviewed, between 42 and 66 percent of survivors said their doctors never asked about hot flashes.
Nearly three quarters got less than ten minutes to discuss menopause concerns with their team.
What survivors can ask for
Rachel Frankenthal is a certified menopause clinician at UCLA Health's Comprehensive Menopause Program.
She has said every cancer survivor deserves an individualized conversation about her symptoms and the options for treating them.
Also read: Living near water pollution may raise risk of rare brain disease
Non-hormone approaches include cognitive behavioral therapy, regular exercise and certain antidepressants that can reduce hot flashes.
Hormone therapy remains an option for some survivors but depends on the cancer type and must be weighed carefully with the oncology team.
Charities such as Menopause and Cancer, founded by cancer survivor Dani Binnington, offer peer-led support for women navigating this.
Anyone struggling with severe symptoms after cancer treatment can ask their oncology team or primary care doctor for a referral to a menopause specialist.
This article is made and published by Ida-Marie Palm Varbæk, who may have used AI in the preparation.